Androgen-responsive FOXP4 is a target for endometrial carcinoma
Abstract Although low estrogen is considered to suppress uterine endometrial carcinoma, the most cases occur in the postmenopausal stage. After menopause, the production of androgen level also declines. Therefore, to resolve the above enigma, we hypothesize that the postmenopausal decline of androge...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-06-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-024-06433-w |